Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x100px

Product › Details

therapeutic vaccine

	Next higher product group	vaccine

Record changed: 2023-02-23

Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x200px

More documents for vaccine

[1] Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen....
[2] Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing"....
[3] Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets...
[4] Bavarian Nordic A/S. (12/6/21). "Press Release: Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base". Copenhagen....
[5] Bavarian Nordic A/S. (12/6/21). "Press Release: Bavarian Nordic A/S Announces Completion of Directed Issue of 6,373,680 New Ordinary Shares [Not for US, CA, JP, et al.]". Copenhagen....
[6] Bavarian Nordic A/S. (12/5/21). "Press Release: Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate". Copenhagen....
[7] Nykode Therapeutics A/S. (11/23/21). "Press Release: Nykode Therapeutics (formerly Vaccibody*)) Enters into Multi-target License and Collaboration Agreement with Regeneron to Develop Innovative Vaccines against Cancer and Infectious Diseases". Oslo....
[8] Insilico Biotechnology AG. (8/24/21). "Press Release: Insilico Biotechnology AG Participates in Inno4vac, a European new public-private partnership to innovate vaccine development". Stuttgart....
[9] Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA....
[10] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)